RVC?s venture fund invests in next gen ion-exchange technology

Bioprocess Capital Ventures, a Russian VC fund, has bought into Axion ? Rare and Precious Metals, a Russian project developing technology for ion-exchange materials.

Bioprocess Capital Ventures, a VC fund set up by Russian Venture Company (RVC), has bought into Axion ? Rare & Precious Metals, RVC announced earlier this week. The deal?s value has yet to be specified; the source only disclosed that the investment was expected to help fine-tune the technology of making the new AXION ion-exchange materials and produce trial runs of such materials for industrial testing. Axion ? Rare & Precious Metals, a Bioprocess Capital Ventures portfolio company, was set up three years ago to focus on the development of Russian ion-exchange materials possessing adaptive selectivity properties. The technology is believed to be able to considerably improve the efficiency of processing rare metal containing raw material. AXION, the company?s flagship new product, is an ion-exchange polymer reportedly capable of extracting uranium, thorium, indium, rare-earths, scandium, cesium, lithium and other ions from compound chemical solutions with a high degree of selectivity...